US becomes fourth country to get EU API waiver
This article was originally published in SRA
Executive Summary
The US has become the fourth country to be included on the European Commission's list of third countries that will be exempt from the burden of having to issue written confirmations to local manufacturers of active pharmaceutical ingredients (APIs) who wish to export their products to the EU1-3.